ERBA Diagnostics, Inc. Reports Second Quarter 2013 Financial Results

Revenues increased by 60% and gross profit up by 56% for the second quarter

Posts positive net income for the second quarter

Continuing integration and consolidation with its recently acquired subsidiary, Drew Scientific, expected to lead to higher revenues and lower operating expenses

(0)

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP